Glenmark to launch generic drug to treat metabolic acidosis in US
[ad_1] Glenmark Pharmaceuticals on Tuesday said it will launch a generic medication, used to treat high acid levels in the body, in the US market. Glenmark Pharmaceuticals Inc., USA, is gearing up to launch 8.4 per cent Sodium Bicarbonate Injection in a single-dose vial, the Mumbai-based drug firm said in a regulatory filing. The company’s…